If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
MINNEAPOLIS, March 17 (HSMN NewsFeed) — On March 17, 2010 the FDA gave approval to Envoy Clinical Corporation to market a "First of its Kind" prosthetic hearing restoration device. The approval follows a December 18, 2009 unanimous Fifteen to 0 vote…
Devices, FDA
Envoy Pharmaceutical
Posts from ‘March, 2010’
FDA Approves First of Its Kind, Fully Implantable (Surgically), Invisible, Prosthetic Hearing Restoration Device
Boston Scientific Completes Enrollment in PLATINUM Trials for Diminutive Vessels and Long Lesions
Trials to evaluate small vessel and long lesion versions of platinum chromium PROMUS(R) Element(TM) Stent System NATICK, Mass., March 16 (HSMN NewsFeed) — Boston Scientific Corporation (NYSE:BSX ) today announced the completion of patient enrollment …
Devices, Interventional Cardiology
Boston Scientific, platinum chromium, PROMUS Element, drug eluting stent
Caris Life Sciences Announces Two Senior Vice President Appointments
IRVING, Texas, March 16, 2010 –(HSMN NewsFeed) — Caris Life Sciences, Inc. — a top biosciences company focused on enabling precise and personalized healthcare through the highest quality anatomic laboratory, molecular profiling, and blood-based diagn…
Personalized Medicine, Diagnostics, Personnel
Caris Life Sciences
Philips Simplifies Cardiology Care With Technologies That Span the Entire Spectrum of Patient Care
ATLANTA, March Fifteen (HSMN NewsFeed) — At this year’s annual meeting of the American College of Cardiology (ACC), March 14-16 in Atlanta, Royal Philips Electronics (NYSE: PHG, AEX: PHI) will showcase its commitment to simplifying cardiology patient care by…
Devices, Cardiology, Monitoring
Royal Philips Electronics, Hybrid OR , InnerCool
Ranbaxy Announces Settlement of Actos(R) (Pioglitazone Hydrochloride) Patent Litigation
JACKSONVILLE, Fla., March 15 (HSMN NewsFeed) — Ranbaxy Laboratories Limited, along with its wholly owned subsidiary Ranbaxy Pharmaceuticals Inc. (collectively, "Ranbaxy"), announced today that they have reached an agreement with Takeda Pharmac…
Biopharmaceuticals, Generics, Litigation
Ranbaxy Laboratories, Takeda Medical, Actos, Pioglitazone
Inadequate Response to Clopidogrel Leads to Higher Incidence of Big Adverse Cardiac Events in Patients Who have Undergone PCI
Results suggest increased need for quantifying patient response to clopidogrel through point-of-care testing SAN DIEGO, March 15 (HSMN NewsFeed) — Accumetrics, Inc., a privately-held developer and marketer of the VerifyNow® System, the first rapi…
Biopharmaceuticals, Diagnostics, Cardiology
Accumetrics, VerifyNow, antiplatelet agents, clopidogrel
MAQUET Cardiovascular Announces Results From Large Coronary Artery Bypass Graft Surgery Study Showing Favorable Results for Endoscopic Vessel Harvesting Technology
Use of Minimally Invasive VASOVIEW System Decreases Risk of Leg Wound Infection While Providing Medical Outcomes Comparable to Traditional Vein Harvesting Procedure WAYNE, N.J., March 15 (HSMN NewsFeed) — MAQUET Cardiovascular LLC, a big provide…
Devices, Cardiology, Surgery
MAQUET Cardiovascular, Endoscopic Vessel Harvesting, CABG
FDA Panel Recommends Approval with Conditions of Medtronic Deep Brain Stimulation Therapy for Patients with Refractory Epilepsy
MINNEAPOLIS–(HSMN NewsFeed)–The U.S. Food and Drug Administration (FDA) Neurological Devices Panel today voted seven to five to recommend approval with conditions of Deep Brain Stimulation (DBS) Therapy for Epilepsy from Medtronic, Inc. (NYSE: MDT ) as a…
Devices, Neurology, FDA
Medtronic, Deep Brain Stimulation, epilepsy
Medtronic Starts International Study of CoreValve(R) Transcatheter Aortic Valve System
Post-Market Evaluation of Breakthrough Pharmaceutical Device Begins Enrolling Patients; First Implants Occur in Germany MINNEAPOLIS–(HSMN NewsFeed)–Moving to expand the evidence base for the future of structural heart disease therapy, Medtronic, Inc. (NYSE: …
Devices, Cardiology
Medtronic, CoreValve, CoreValve Advance, transcatheter aortic valve system
Endo Pharmaceuticals Announces Appointment of New Chief Operating Officer
CHADDS FORD, Pa., March 12 (HSMN NewsFeed) — Endo Pharmaceuticals (Nasdaq:ENDP ) announced today the appointment of Julie McHugh as the company’s chief operating officer, effective March 15, 2010. Most recently, Ms. McHugh was president and CEO for N…
Biopharmaceuticals, Personnel
Endo Pharmaceuticals
